TP53 and triple-negative breast carcinoma: To test this hypothesis in the immune-competent allograft mouse model, we stably expressed mutp53-R175H or mutp53-R273H in a p53-null mouse mammary tumor cell line 4T1, which is molecularly similar to human triple-negative breast cancer.